fda regulations on semaglutide is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Hims & Hers stock falls

insulin secretion increased 1.5- and 2.9-fold, respectively, and glargine increased the ratio of the C-peptide response during the hyperglycemic clamp by 31%

Many insurers cover treatment for Duchenne muscular dystrophy, which can top $1 million a year, but there are fewer than 50,000 patients with the disease in the United States, according to Pfizer, and not all are candidates for the treatment

The answers below reflect Body Pharm's 2026 product disclosures and the wider MHRA enforcement position

Knowledge is the best antidote to fear

When it comes to reducing side effects, microdosing GLP-1s may backfire

B-Complex (B1, B2, B3, B5, B6) B vitamins are all water-soluble, which means they dont stay in your bloodstream for long